[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,448,933
  • Shares Outstanding, K 193,284
  • Annual Sales, $ 3,221 M
  • Annual Income, $ 348,900 K
  • EBIT $ 429 M
  • EBITDA $ 504 M
  • 60-Month Beta 0.23
  • Price/Sales 3.25
  • Price/Cash Flow 18.97
  • Price/Book 1.68

Options Overview Details

View History
  • Implied Volatility 37.47% (+2.31%)
  • Historical Volatility 27.85%
  • IV Percentile 43%
  • IV Rank 35.65%
  • IV High 55.46% on 02/23/26
  • IV Low 27.50% on 01/15/26
  • Expected Move (DTE 5) 2.34 (4.32%)
  • Put/Call Vol Ratio 0.74
  • Today's Volume 347
  • Volume Avg (30-Day) 1,301
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 36,425
  • Open Int (30-Day) 35,123
  • Expected Range 51.72 to 56.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.83
  • Number of Estimates 5
  • High Estimate $1.00
  • Low Estimate $0.62
  • Prior Year $1.25
  • Growth Rate Est. (year over year) -33.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.46 +3.06%
on 04/29/26
57.44 -5.88%
on 05/05/26
-3.14 (-5.49%)
since 04/08/26
3-Month
52.46 +3.06%
on 04/29/26
66.28 -18.43%
on 02/24/26
-4.07 (-7.00%)
since 02/06/26
52-Week
50.76 +6.50%
on 11/07/25
66.28 -18.43%
on 02/24/26
-5.76 (-9.63%)
since 05/08/25

Most Recent Stories

More News
BMRN Q1 Deep Dive: Amicus Acquisition, Pipeline Milestones, and Order Dynamics Shape Outlook

BMRN Q1 Deep Dive: Amicus Acquisition, Pipeline Milestones, and Order Dynamics Shape Outlook

BMRN : 54.06 (-0.11%)
BioMarin: Q1 Earnings Snapshot

BioMarin: Q1 Earnings Snapshot

BMRN : 54.06 (-0.11%)
BioMarin Pharmaceutical (NASDAQ:BMRN) Misses Q1 CY2026 Revenue Estimates

BioMarin Pharmaceutical (NASDAQ:BMRN) Misses Q1 CY2026 Revenue Estimates

BMRN : 54.06 (-0.11%)
BioMarin Reports First Quarter 2026 Financial and Operating Results

First Quarter 2026 Total Revenues Increased Year-over-year to $766 million

BMRN : 54.06 (-0.11%)
BioMarin's Enzyme Portfolio Momentum Collides With Margin Questions the Street Hasn't Asked Yet

Barchart Research What to Expect from BMRN Earnings BMRN Generated May 1, 2026 Current Price $54.06 EPS Estimate $$0.81 Consensus Rating Moderate Buy Average Move 4.13% BioMarin's Enzyme Portfolio Momentum...

BMRN : 54.06 (-0.11%)
BioMarin Pharmaceutical (BMRN) Reports Earnings Tomorrow: What To Expect

BioMarin Pharmaceutical (BMRN) Reports Earnings Tomorrow: What To Expect

BMRN : 54.06 (-0.11%)
BioMarin's Enzyme Portfolio Momentum Collides With Margin Questions the Street Hasn't Asked Yet

Barchart Research What to Expect from BMRN Earnings BMRN Generated May 1, 2026 Current Price $54.06 EPS Estimate $$0.81 Consensus Rating Moderate Buy Average Move 4.13% BioMarin's Enzyme Portfolio Momentum...

BMRN : 54.06 (-0.11%)
BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and Growth in Children With Achondroplasia at the Pediatric Endocrine Society's 2026 Annual Meeting

VOXZOGO is the only approved treatment for children with achondroplasia starting at birth, with over 10 years of clinical research demonstrating the long-term benefit on complications associated with achondroplasia...

BMRN : 54.06 (-0.11%)
BioMarin's Enzyme Portfolio Momentum Collides With Margin Questions the Street Hasn't Asked Yet

Barchart Research What to Expect from BMRN Earnings BMRN Generated May 1, 2026 Current Price $54.06 EPS Estimate $$0.81 Consensus Rating Moderate Buy Average Move 4.13% BioMarin's Enzyme Portfolio Momentum...

BMRN : 54.06 (-0.11%)
BioMarin Completes Acquisition of Amicus Therapeutics

Acquisition Adds Galafold ® (migalastat) for Fabry Disease and Pombiliti ® (cipaglucosidase alfa-atga) + Opfolda ® (miglustat) for Pompe Disease to BioMarin's...

BMRN : 54.06 (-0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder),...

See More

Key Turning Points

3rd Resistance Point 55.58
2nd Resistance Point 55.07
1st Resistance Point 54.56
Last Price 54.06
1st Support Level 53.54
2nd Support Level 53.03
3rd Support Level 52.52

See More

52-Week High 66.28
Fibonacci 61.8% 60.35
Fibonacci 50% 58.52
Fibonacci 38.2% 56.69
Last Price 54.06
52-Week Low 50.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.